MétaCan
Menu
Back to cohort

Actovegin Improves Skeletal Muscle Mitochondrial Respiration And Functional Aerobic Capacity In Type 1 Diabetes

2023· article· en· W4387054778 on OpenAlexaff
Brandon Kosik, Steen Larsen, Andreas Bergdahl

Bibliographic record

VenueMedicine & Science in Sports & Exercise · 2023
Typearticle
Languageen
FieldNeuroscience
TopicNeurological Disorders and Treatments
Canadian institutionsConcordia University
Fundersnot available
KeywordsSkeletal muscleRespirationInternal medicineEndocrinologyAerobic capacityCellular respirationRespirometryBiologyMedicineAnatomyBiochemistry

Abstract

fetched live from OpenAlex

BACKGROUND: Insulin deficiency in type 1 diabetes (T1D) leads to an impairment of glucose metabolism and mitochondrial function. Actovegin is a deproteinized calf blood extract which has been shown to enhance cell metabolism and muscle repair in healthy human skeletal muscle. PURPOSE: To determine the effects of Actovegin on skeletal muscle mitochondrial respiration and functional aerobic capacity in a type 1 diabetic mouse model. Outcomes on body mass, food and water consumption were also investigated. METHODS: Type 1 diabetic, male, C57B1/6 mice were randomized to an Actovegin and a control group. Every third day, for 13 days, the Actovegin (n = 11) and control group (n = 10) were injected intraperitoneally with 0.1 ml (25% v/v) Actovegin and 0.1 ml physiological salt solution, respectively. Mitochondrial respiratory capacity of the vastus lateralis was measured by high resolution respirometry. Functional aerobic capacity was assessed by recording maximum running time on a rodent treadmill using an endurance exercise protocol. Body mass, food and water consumption were measured using an electronic balance scale. A two-way ANOVA was used to establish between-group comparisons for functional aerobic capacity, body mass, food, and water consumption. A two-tailed independent samples T-test was used to compare the mean difference in mitochondrial respiration between groups. RESULTS: After 13 days, in comparison to the control group, the Actovegin group demonstrated a significantly higher maximal skeletal muscle mitochondrial respiration rate (Actovegin: 29.7 ± 2.87 pmol/sec*mg versus control: 18.5 ± 2.13 pmol/sec*mg, P = 0.006). The Actovegin group also displayed a significantly lesser % decline in baseline functional aerobic capacity (Actovegin: -32.4 ± 13.8 % versus control: -74.6 ± 12.5 %, P = 0.004) and baseline body mass (Actovegin: -9.25 ± 0.97 % versus control: -13.15 ± 1.68 %, P = 0.005) after 13 days. CONCLUSIONS: Actovegin could act as an effective agent for improving mitochondrial respiratory capacity and functional aerobic capacity in T1D. Further investigation is warranted to establish Actovegin’s potential as an alternative therapeutic drug for T1D. There is no grant-funding associated with this study.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.041
GPT teacher head0.267
Teacher spread0.226 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueMedicine & Science in Sports & ExerciseSame topicNeurological Disorders and TreatmentsFrench-language works237,207